Olivia Lauk
University of Zurich
Internal medicineRadiologySurgeryPathologyOncologyResectionStage (cooking)Induction chemotherapyChemotherapyRadical surgeryMesotheliomaEmpyemaCisplatinPericardiumDecorticationSalvage therapyExtrapleural PneumonectomyNuclear medicinePleural mesotheliomaRat modelVolume (compression)Radiation therapyFibrinMedicineComplication
45Publications
6H-index
135Citations
Publications 46
Newest
#1Olivia Lauk (UZH: University of Zurich)H-Index: 6
#2Miriam Patella (UZH: University of Zurich)H-Index: 8
Last. Ilhan Inci (UZH: University of Zurich)H-Index: 23
view all 11 authors...
OBJECTIVES Tumor thickness and tumor volume measured by computed tomography (CT) were suggested as valuable prognosticator for patients' survival diagnosed with malignant pleural mesothelioma (MPM). The purpose was to assess the accuracy of CT scan based preoperatively measured tumor volume and thickness compared to actual tumor weight of resected MPM specimen and pathologically assessed tumor thickness, as well as an analysis of their impact on overall survival (OS). METHODS Between 09/2013-08/...
Source
#1Claudio CaviezelH-Index: 5
#2Didier SchneiterH-Index: 20
Last. Isabelle OpitzH-Index: 26
view all 4 authors...
Source
#1J.P. Ehrsam (UZH: University of Zurich)H-Index: 3
#2Olivia Lauk (UZH: University of Zurich)H-Index: 6
Last. Ilhan Inci (UZH: University of Zurich)H-Index: 23
view all 7 authors...
Introduction Lobar lung transplantation (LLTx) allows the use of oversized grafts for small recipients. In this technically demanding and not widely adopted procedure, prolonged air leak, kinking of vascular anastomoses and remaining dead space are frequent complications. We describe our experience in treatening the rarely reported bronchial stump insu!cency (BSI) after LLTx. Case Report Between 1993-2016 we performed 120 cases of LLTx in our center. Among these, 3 developed BSI with empyema. A)...
Source
Source
#1Olivia LaukH-Index: 6
#2Katarzyna Furrer (UZH: University of Zurich)H-Index: 7
Last. Isabelle OpitzH-Index: 26
view all 8 authors...
Source
#2Mayura MeerangH-Index: 8
Last. Isabelle OpitzH-Index: 26
view all 11 authors...
Source
#1Stefanie Hiltbrunner (UZH: University of Zurich)H-Index: 5
#2Christian Britschgi (UZH: University of Zurich)H-Index: 6
Last. Alessandra Curioni-Fontecedro (UZH: University of Zurich)H-Index: 20
view all 20 authors...
8 CitationsSource
#1Olivia LaukH-Index: 6
Last. Isabelle OpitzH-Index: 26
view all 10 authors...
Objectives Adding bevacizumab, an anti-Vascular Endothelial Growth Factor (VEGF), to platinum-based chemotherapy/pemetrexed in 1st line treatment of advanced malignant pleural mesothelioma (MPM), significantly improved overall survival. However, increased high grade bleeding after operation was reported in patients with colorectal cancer who previously received bevacizumab. In the present analysis, we assessed for the first time the impact of adding bevacizumab to induction chemotherapy prior to...
Source
#1Raphael S. WernerH-Index: 4
#2Olivia LaukH-Index: 6
Last. Isabelle OpitzH-Index: 26
view all 3 authors...
Background: For patients with malignant pleural mesothelioma (MPM), a multimodality treatment concept including neoadjuvant chemotherapy and radical surgery offers improved overall survival. While the lung-sparing extended pleurectomy and decortication (EPD) has become the preferential surgical approach, the more aggressive extrapleural pneumonectomy (EPP) remains reserved for a selected group of patients. Based on our experience from the past two decades, we aim to discuss and assess today’s ro...
Source
#1Raphael S. WernerH-Index: 4
#2Claudio CaviezelH-Index: 5
Last. Isabelle OpitzH-Index: 26
view all 4 authors...
Malignant pleural mesothelioma (MPM) is a rare tumor of the visceral and parietal pleura that is most commonly associated with occupational exposure to asbestos. Since tumor biology is both aggressive and highly heterogeneous at histopathological and molecular level, prediction of prognosis and treatment effect remains challenging. Up to date, the best outcome in primary treatment is achieved by a multimodality approach that includes chemotherapy, followed by macroscopic complete resection (MCR)...
1 CitationsSource